Genetic Testing Clinical Trials
2 recruiting trials for Genetic Testing. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Genetic Testing clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Universitaire Ziekenhuizen KU Leuven (1), University of Maryland, Baltimore (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Genetic testing (other, 1 trial), followed by Direct contact of family members for cascade screening of relevant variants.
Track Genetic Testing trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
Pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) is associated with considerable morbidity and even mortality. Next to environmental risk...
Comparing Direct vs Indirect Methods for Cascade Screening
An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are identified, also known...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Genetic Testing, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Genetic Testing, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Genetic Testing, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.